Skip to main content
drug protocol number
CA209-227
drug sponsor
Bristol-Myers Squibb
drug study
NIVOLUMAB/IPILIMUMAb
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh)
drug status
Terminated
drug phase